Company intelligence / Profile preview

OntoChem

Halle (Saale), Saxony-Anhalt, Germanyontochem.com ↗
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

OntoChem does not run clinical trials—previous drug discovery technologies/projects (e.g., COVID-19 antivirals) have been spun out/assigned to other companies

Modalities
small moleculeproteincompoundsontologies
Industry
Drug Discovery Services
02

Partnerships

Anixa Biosciences (collaboration on COVID-19 antiviral drug discovery, now assigned to MolGenie)Digital Science (acquisition/continuing integration)

Beyond the preview

Go deeper on OntoChem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OntoChem.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call